Cuffe Michael S. 4
4 · HCA Healthcare, Inc. · Filed Sep 8, 2025
Insider Transaction Report
Form 4
Cuffe Michael S.
EVP and Chief Clinical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-09-04$173.12/sh+10,920$1,890,470→ 42,422.902 total - Sale
Common Stock
2025-09-08$418.84/sh−3,836$1,606,670→ 31,502.902 total - Tax Payment
Common Stock
2025-09-04$411.59/sh−7,084$2,915,704→ 35,338.902 total - Exercise/Conversion
Stock Appreciation Right
2025-09-04−10,920→ 10,000 totalExercise: $173.12Exp: 2031-02-03→ Common Stock (10,920 underlying)
Footnotes (3)
- [F1]The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2025.
- [F2]Includes 2,595.9017 shares acquired under the Issuer's employee stock purchase plans.
- [F3]The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022.